Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.15% | 3.80% | 10.35% | 12.28% | 16.30% |
| Total Depreciation and Amortization | -6.32% | -6.85% | -9.89% | -13.64% | -11.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.76% | -13.94% | 17.77% | 63.79% | 160.55% |
| Change in Net Operating Assets | 121.81% | -82.67% | 132.62% | 37.61% | -4.03% |
| Cash from Operations | 19.13% | -4.83% | 31.09% | 21.96% | 23.27% |
| Capital Expenditure | 47.46% | 72.69% | 67.38% | 64.70% | 47.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 47.46% | 72.69% | 67.38% | 64.70% | 47.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.09% | -6.01% | -20.32% | -44.76% | -54.62% |
| Issuance of Common Stock | 33.54% | 130.47% | -10.32% | 30.78% | -9.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -150.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Cash from Financing | 33.63% | 135.98% | -13.50% | 26.16% | -14.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.31% | 104.20% | 101.70% | 88.81% | 35.92% |
